Periodontitis, periodontopathic bacteria and lactoferrin.

Area of Science:

• Oral microbiology
• Immunology
• Biochemistry

Background:

• Lactoferrin (LF) is a salivary protein with antimicrobial properties.
• Periodontitis is a common oral disease driven by specific bacteria.
• LF's role against periodontopathic bacteria and its association with periodontitis severity are under investigation.

Purpose of the Study:

• To investigate the efficacy of Lactoferrin (LF) against periodontopathic bacteria.
• To evaluate LF's impact on bacterial biofilm formation and established biofilms.
• To assess the clinical effect of oral LF administration on subgingival plaque bacteria.

Main Methods:

• Assessing LF's antibacterial activity against planktonic and biofilm forms of P. gingivalis and P. intermedia.
• Conducting a clinical study on chronic periodontitis patients receiving oral bovine LF.
• Analyzing subgingival plaque samples for bacterial load.

Main Results:

• LF demonstrated antibacterial activity against planktonic P. gingivalis and P. intermedia at high concentrations.
• LF effectively inhibited biofilm formation and reduced established biofilms of these bacteria at physiological concentrations.
• Oral administration of bovine LF led to a reduction in P. gingivalis and P. intermedia in patient subgingival plaque.

Conclusions:

• Lactoferrin exhibits significant biofilm inhibitory effects against periodontopathic bacteria in vitro.
• Oral LF administration shows promise in reducing key periodontopathic bacteria in vivo.
• LF is a potential therapeutic agent for managing periodontitis by targeting bacterial biofilms.